Molecular basis of atrial fibrillation pathophysiology and therapy: a translational perspective

S Nattel, J Heijman, L Zhou, D Dobrev - Circulation research, 2020 - Am Heart Assoc
Atrial fibrillation (AF) is a highly prevalent arrhythmia, with substantial associated morbidity
and mortality. There have been significant management advances over the past 2 decades …

Cardiac alternans: from bedside to bench and back

Z Qu, JN Weiss - Circulation research, 2023 - Am Heart Assoc
Cardiac alternans arises from dynamical instabilities in the electrical and calcium cycling
systems of the heart, and often precedes ventricular arrhythmias and sudden cardiac death …

Atrial myocyte NLRP3/CaMKII nexus forms a substrate for postoperative atrial fibrillation

J Heijman, AP Muna, T Veleva, CE Molina… - Circulation …, 2020 - Am Heart Assoc
Rationale: Postoperative atrial fibrillation (POAF) is a common and troublesome
complication of cardiac surgery. POAF is generally believed to occur when postoperative …

[HTML][HTML] Interleukin-6-mediated-Ca2+ handling abnormalities contributes to atrial fibrillation in sterile pericarditis rats

J Liao, S Zhang, S Yang, Y Lu, K Lu, Y Wu… - Frontiers in …, 2021 - frontiersin.org
Pre-existing Ca 2+ handling abnormalities constitute the arrhythmogenic substrate in
patients developing postoperative atrial fibrillation (POAF), a common complication after …

Advances in basic and translational research in atrial fibrillation

D Hu, H Barajas-Martinez… - … of the Royal …, 2023 - royalsocietypublishing.org
Atrial fibrillation (AF) is a very common cardiac arrhythmia with an estimated prevalence of
33.5 million patients globally. It is associated with an increased risk of death, stroke and …

[HTML][HTML] Dapagliflozin reduces the vulnerability of rats with pulmonary arterial hypertension-induced right heart failure to ventricular arrhythmia by restoring calcium …

J Wu, T Liu, S Shi, Z Fan, R Hiram, F Xiong… - Cardiovascular …, 2022 - Springer
Background Malignant ventricular arrhythmia (VA) is a major contributor to sudden cardiac
death (SCD) in patients with pulmonary arterial hypertension (PAH)-induced right heart …

RyR2 inhibition with dantrolene is antiarrhythmic, prevents further pathological remodeling, and improves cardiac function in chronic ischemic heart disease

J Schmeckpeper, K Kim, SA George… - Journal of Molecular and …, 2023 - Elsevier
Diastolic Ca 2+ leak due to cardiac ryanodine receptor (RyR2) hyperactivity has been widely
documented in chronic ischemic heart disease (CIHD) and may contribute to ventricular …

[HTML][HTML] Revisiting antiarrhythmic drug therapy for atrial fibrillation: reviewing lessons learned and redefining therapeutic paradigms

M Geng, A Lin, TP Nguyen - Frontiers in Pharmacology, 2020 - frontiersin.org
Since the clinical use of digitalis as the first pharmacological therapy for atrial fibrillation (AF)
235 years ago in 1785, antiarrhythmic drug therapy has advanced considerably and …

Atrial fibrillation in horses part 1: Pathophysiology

A Decloedt, G Van Steenkiste, L Vera, R Buhl… - The Veterinary …, 2020 - Elsevier
Atrial fibrillation (AF) is the most common clinically relevant arrhythmia in horses, with a
reported prevalence up to 2.5%. The pathophysiology has mainly been investigated in …

[HTML][HTML] Molecular insights in atrial fibrillation pathogenesis and therapeutics: a narrative review

KA Papathanasiou, SG Giotaki, DA Vrachatis, G Siasos… - Diagnostics, 2021 - mdpi.com
The prevalence of atrial fibrillation (AF) is bound to increase globally in the following years,
affecting the quality of life of millions of people, increasing mortality and morbidity, and …